The Future Management of IPF: Advanced
Diagnostic & Treatment Strategies
A continuing medical education activity sponsored by NAMCP and AAMCN.
This activity is an archive from the
live session at the 2017 Fall Forum. If you participated in
the live session, you are not eligible for continuing education
credits from this archive.
This activity is valid from February
20, 2018 to February 28, 2019
Instructions for CME/CNE: Complete the pre-test, listen to the audio
and view the slides, complete the post test, complete the evaluation
form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your
internet browser without completing the post test, you will have ONE
more opportunity to complete. A score of 70% must be achieved on the
post test to receive continuing education credits. If you do not
pass the post test after two attempts, you will not be eligible to
try again. Once you complete the evaluation form and score 70% or
higher on your post test, you will automatically be given your
To print or save your certificate, you will need to click on the
“download” button and either print or save.
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This presentation is supported by an
educational grant from
Idiopathic pulmonary fibrosis (IPF) is a devastating disease
associated with irreversible destruction of the lung(s) which
progressively worsens, making it difficult for patients to breathe
as well as keep adequate levels of oxygen in the bloodstream. The
condition frequency increases with age, is more common in men than
in women, and has a median survival rate of 4 years or less from the
time of diagnosis. IPF is the most common of the idiopathic
interstitial pneumonias and typically has a poor prognosis as the
disease exhibits a gradual onset, making it difficult to diagnosis
early. Earlier diagnosis begins with elicitation of a thorough and
extensive medical history that includes a review of symptoms/signs
suggestive of a systemic disorder, occupational and environmental
exposures, use of medications and drugs, and family medical history.
Despite a growing prevalence, patients with IPF continue to suffer
delays in diagnosis, increased costs, and a reduction in patient
quality of life and overall survival.
Treatment strategies for IPF aim at managing the symptoms and
slowing disease progression to best maintain a patient’s quality of
life. The therapeutic landscape is rapidly evolving and current and
emerging therapies are shown to slow disease progression which
ultimately brings about a need for earlier diagnosis and
intervention in IPF. More recently, therapeutic options for IPF have
evolved to include targeted agents that have the ability to
individualize treatment for patients. The standard of care for IPF
includes oxygen supplementation, management of co-morbidities, lung
transplants, and implementing nintedanib and pirfenidone, according
to updated guidelines.
Upon Completion of this
activity, participants will be able to:
Identify the available guidelines
and approaches for the management of patients with IPF
Assess the diagnostic workup and
criteria as well as the role of the multidisciplinary team in
ensuring an early and accurate diagnosis of IPF
Explore the clinical data and
emerging research related to IPF treatment
Discuss the current and emerging
therapies that reflect current evidence and available guidelines
that are individualized to patients
Evaluate the appropriate process
with patients and/or caregivers in overcoming barriers in IPF
||Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Associate Dean for Diversity and Inclusion
UC Irvine School of Medicine
UC Irvine Program in Medical Education for the Latino
has no relevant financial relationships to disclose. His
presentation has been peer reviewed for any bias.
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
NAMCP designates this enduring material for a maximum of 1 AMA PRA
Category I creditsTM.
The American Association of Managed Care Nurses is accredited as a
provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission
Nurses who complete this activity and achieve a passing score will
receive 1 hour in continuing
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
supported by an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue